CoEHAR’s REPLICA Project evaluates nicotine-related science to ensure that policymakers and the public receive correct and reliable information.Read More
also-in-tr.jpg
BAT’s write-down of its U.S. cigarette brands is a step toward a resilient future, argues Brand Finance’s Richard Haigh.Read More
Producing tobaccos with ‘minimally addictive’ levels of nicotine presents significant challenges.Read More
Making e-cigarettes available only on prescription may be a net negative for public health, writes Neil McKeganey. Read More
British American Tobacco's Eirini Vlanti shares her insights into biodiversity in the tobacco and nicotine industryRead More
E-cigarettes enjoy booming popularity in the CIS region—but not among the countries' lawmakers.Read More
Driven by cost considerations and growing environmental awareness, do-it-yourself cigarette papers continue to gain popularity. Read More
Applied properly, age estimation technology can be a valid tool to discourage youth access. Read More
As it seeks to reduce its reliance on tobacco, Zimbabwe is investing in cannabis research. Read More
Boosted by a significant private equity investment, CME Automation Systems is strengthening its offerings. Read More
